Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07248943Not ApplicableNot Yet Recruiting

Contralateral Neural Tissue Mobilization for Cervical Radiculopathy

Role: collaborator

NCT06330831Not ApplicableCompleted

Intensive Group Based CIMT for Young Children

Role: lead

NCT06067607Not ApplicableUnknown

Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment

Role: lead

NCT05498077Not ApplicableUnknown

Immediate Effects of a 10-minute Body Scan Meditation on People Who Has Central Sensitization

Role: collaborator

All 4 trials loaded